Equity Issuances

Stonepeak-Plus Infrastructure Fund LP issued Class I-1 71,005 of unit to third party investors for $2,148,000.

“by the Fund to third party investors (rounding to the nearest whole number): Number of Units Sold (2) Aggregate Consideration Class A-1a 922,106 $27,575,000 Class I-1 71,005 $2,148,000 (1) The Fund invests generally alongside another vehicle that is managed by Stonepeak-Plus Infrastructure Fund Advisors LLC, its investment advisor (the “Investment Advisor”), is”

Stonepeak-Plus Infrastructure Fund LP issued Class A-1a 922,106 of unit to third party investors for $27,575,000.

“details on the Units sold by the Fund to third party investors (rounding to the nearest whole number): Number of Units Sold (2) Aggregate Consideration Class A-1a 922,106 $27,575,000 Class I-1 71,005 $2,148,000 (1) The Fund invests generally alongside another vehicle that is managed by Stonepeak-Plus Infrastructure Fund Advisors LLC, its investment advisor”

BlackRock Monticello Debt Real Estate Investment Trust issued 807,096.4118 common shares of common stock to third party investors and one or more officers and trustees for $20,270,500.

“on January 2, 2026, the Company sold an aggregate of 807,096.4118 common shares (the “Shares”) for aggregate consideration of $20,270,500 to third party investors and one or more officers and trustees of the Company, plus applicable upfront selling commissions and dealer manager fees”

PNC FINANCIAL SERVICES GROUP, INC. issued 115,200 shares of preferred stock to former holders of 7.250% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B, par value $1,000 per share, of FirstBank.

“At the effective time of the First Step Merger, PNC issued 115,200 shares of PNC Series X Preferred Stock to former holders of 7.250% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B, par value $1,000 per share, of FirstBank”

TRIO-TECH INTERNATIONAL issued common stock.

“On December 19, 2025, Trio-Tech International (the “ Company ”) announced a two-for-one forward stock split (the “ Stock Split ”) of the Company’s issued common stock”

NOCOPI TECHNOLOGIES INC/MD/ issued 266,666 shares of the Company’s common stock of common stock to various institutional investors (the "Purchasers") for $1.50 per share.

“The Purchase Agreements provide for the private issuance (the “ Private Placement ”) to the Purchasers of an aggregate of 266,666 shares of the Company’s common stock, par value $0.01 per share (the “ Common Stock ” and such shares of Common Stock issued pursuant to the Private Placement, the “ Placement Shares ”) at a purchase price of $1.50 per share.”

Eledon Pharmaceuticals, Inc. issued pre-funded warrant to purchase up to 4,203,764 shares of Common Stock of warrant to Coastlands Capital Partners LP.

“the Holder agreed to exchange 4,203,764 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), for a pre-funded warrant to purchase up to 4,203,764 shares of Common Stock (the “Exchange Warrant” and such exchange of Common Stock for the Exchange Warrant is referred to herein as the “Exchange”).”

Two Hands Corp issued convertible promissory note in the principal amount of $94,300 of convertible note to Vanquish Funding Group LLC for purchase price of $82,000.

“the Company sold and Vanquish purchased a convertible promissory note in the principal amount of $94,300 (the “ Note ”), for a purchase price of $82,000 (the “ Transaction ”). The Transaction closed on or about December 4, 2025”

iSpecimen Inc. issued 6,875 shares of Series C Preferred Stock of preferred stock to certain accredited investors for aggregate purchase price of $5.5 million.

““Floor Price”). Pursuant to the Purchase Agreement, on December 31, 2025, the Company issued and sold 6,875 shares of Series C Preferred Stock for an aggregate purchase price of $5.5 million at the closing (the “Closing”). In connection with the Purchase Agreement, the Company also entered into a Registration Rights Agreement with the Investors (the “Registration”

SKYX Platforms Corp. issued 20,000 shares of preferred stock to existing and new strategic investors for $500,000 gross proceeds.

“On December 30, 2025, SKYX Platforms Corp. (the “Company”) signed and closed on Securities Purchase Agreements (the “Purchase Agreements”) from an existing and a new strategic investor for gross proceeds of $500,000. Pursuant to the Purchase Agreements, the investors purchased 20,000 shares of the Company’s Series A-2 Preferred Stock, no par value per share (the “Series A-2 Preferred Stock”), at a purchase price of $25.00 per share with no price protection.”

SKYX Platforms Corp. issued common stock to a member of the Company’s Board of Directors for $835,900, representing the full principal balance plus accrued and unpaid interest from 2020.

“On December 31, 2025, a member of the Company’s Board of Directors converted $835,900, representing the full principal balance plus accrued and unpaid interest from 2020, under his Subordinated Convertible Balloon Promissory Note issued by SKYX Platforms Corp. (the “Company”) on November 3, 2020 (the “Note”) into shares of the Company’s common stock.”

Cottonwood Communities, Inc. issued 227,819 shares of preferred stock to accredited investors for $10.00 per share.

“to which it is offering a maximum of $150,000,000 in shares of its Series A Convertible Preferred Stock to accredited investors (the "Private Offering") at a purchase price of $10.00 per share. The exemption is available to the Company because the shares are being offered and sold solely to accredited investors without the use of general solicitation. Sales of”

INTELLIGENT BIO SOLUTIONS INC. issued 2,298,850 shares of warrant to two healthcare focused institutional investors for $4.10 per share.

“Each Series K-1 Warrant and Series K-2 Warrant is exercisable into one share of Common Stock at a price per share of $4.10 (as adjusted from time to time in accordance with the terms thereof).”

INTELLIGENT BIO SOLUTIONS INC. issued 2,298,850 shares of common stock to two healthcare focused institutional investors for $4.35 per share.

“The combined purchase price of one share of Common Stock (or one Pre-Funded Warrant) and accompanying Series K-1 Warrant and Series K-2 Warrant was $4.35. The Offering closed on January 2, 2026. At the closing of the Offering, 105,000 Shares were issued and 2,193,850 Pre-Funded Warrants were issued.”

Stone Point Credit Corp issued 2,516,723.6084 shares of common stock to accredited investors for $49,999,999.60.

“Stone Point Credit Corporation (the “Company”) issued and sold 2,516,723.6084 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), on December 30, 2025 for an aggregate offering price of $49,999,999.60.”

Energy Vault Holdings, Inc. issued convertible note to YA II PN, Ltd. for $15.0 million of Debentures.

“On December 30, 2025, the Company and the Investor entered into an amendment to the Purchase Agreement (the "Amendment"), pursuant to which the Company agreed to issue and sell an additional $15.0 million of Debentures to the Investor (the "Third Closing").”

Zura Bio Ltd issued 8,657,402 Class A ordinary shares of common stock to Athanor Capital.

“the Company agreed to issue to Athanor 8,657,402 Class A ordinary shares, of par value US$0.0001 each, of the Company (the "Athanor Shares")”

Rani Therapeutics Holdings, Inc. issued common stock.

“As a result of the adoption of the Amended and Restated Certificate of Incorporation (as so amended and restated, the “Restated Charter”), the rights of holders of the Company’s common stock were materially modified, including, among other things, a reduction in the voting power of the Company’s Class B common stock from ten (10) votes per share to one (1) vote per share.”

Cingulate Inc. issued 72,957 shares of Common Stock at a value of $4.11 per share of common stock to lender for exchange for a portion of the debt owed to such lender.

“January 2, 2026, the Company issued 72,957 shares of Common Stock at a value of $4.11 per share to a lender in exchange for a portion of the debt owed to such lender.”

Cingulate Inc. issued 80,645 shares of Common Stock at a value of $3.72 per share of common stock to lender for exchange for a portion of the debt owed to such lender.

“On December 4, 2025, the Company issued 80,645 shares of Common Stock at a value of $3.72 per share to a lender in exchange for a portion of the debt owed to such lender.”

Cingulate Inc. issued 73,746 shares of Common Stock at a value of $3.39 per share of common stock to lender for exchange for a portion of the debt owed to such lender.

“On November 21, 2025, the Company issued 73,746 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a value of $3.39 per share to a lender in exchange for a portion of the debt owed to such lender.”

AGL Private Credit Income Fund issued 2,139,495.08 common shares of common stock to shareholders for $50,000,000 aggregate offering price.

“On December 29, 2025, AGL Private Credit Income Fund (the “ Company ”) closed the sale of 2,139,495.08 of the Company’s common shares of beneficial interest, par value $0.001 per share (the “ Common Shares ”), for an aggregate offering price of $50,000,000.”

Fusemachines Inc. issued 588,235 shares of common stock to Consilium Frontier Equity Fund LP for $1.70 per share.

“On December 23, 2025, Fusemachines Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with Consilium Frontier Equity Fund LP, an existing shareholder in the Company (the “ Investor ”), pursuant to which the Company agreed to issue and sell, in a private placement (the “ Offering ”), 588,235 shares of the Company’s common stock, par value $0.0001 per share, at a purchase price of $1.70 per share, to the Investor (the “ Shares ”).”

Viewbix Inc. issued warrant to purchase 32,000 shares of Common Stock of warrant to L.I.A. Pure Capital Ltd. (the Advisor) for commission for advisory services, conditioned upon closing of the Private Placement Offering.

“The Company agreed to pay a commission to the Advisor of (i) a cash fee of $70,000 and (ii) a warrant to purchase 32,000 shares of Common Stock (the “Advisor Warrant”).”

Viewbix Inc. issued 800,000 shares of Common Stock (or pre-funded warrants) and warrants to purchase up to 640,000 shares of Common Stock of unit to certain accredited investors for combined purchase price of $1.75 per Private Placement Share and accompanying Common Warrant and $1.74999 per Pre-Funded Warrant and accompanying Common Warrant.

“On January 1, 2026, the Company entered into an amended and restated securities purchase agreement (the “Purchase Agreement”) with the Investors pursuant to which the Company agreed to sell and issue in the Private Placement Offering an aggregate of 800,000 shares of Common Stock (the “Private Placement Shares”) or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”) in lieu of the Private Placement Shares. Each Private Placement Share and Pre-Funded Warrant will be sold together with a number of warrants equal to 80% of the aggregate number of Private Placement Shares and Pre-Funded Warrants sold in the Private Placement Offering, or in total warrants to purchase up to an aggregate of 640,000 shares of Common Stock (the “Common Warrants” and together with the Pre-Funded Warrants, the “Warrants”, and the Warrants together with the Private Placement Shares, the “Securities”), at a combined purchase price of $1.75 per Private Placement Share and accompanying”

QHSLab, Inc. issued 421,827 shares of common stock to Alex Mirakian MD PA for conversion of $126,548 of principal and accrued interest at $0.30 per share.

“the Company issued 421,827 shares of its common stock to Alex Mirakian MD PA in exchange for the conversion of $126,548 of principal and accrued interest under the Original Note. The shares were issued at an effective price of $0.30 per share.”

MGT CAPITAL INVESTMENTS, INC. issued 300,000,000 Shares of common stock to several accredited investors for $300,000 in Common Stock.

“conducted on a rolling closing basis and is scheduled to terminate on January 31, 2026. As of the date of this filing, the Company has closed on the sale of an aggregate of $300,000 in Common Stock. The proceeds will be used for general working capital purposes. ate on January 31, 2026. As of the date of this filing, the Company has closed on the sale of an”

Ainos, Inc. issued 1,160,000 shares of common stock of common stock to ScentAI Inc. for in exchange for 116,000,000 shares of common stock to be issued by ScentAI.

“On December 30, 2025, following the approval by the board of directors of Ainos, Inc. (the “Company”), the Company issued 1,160,000 shares of common stock (“AIMD Shares”), par value $0.01 (the “Common Stock”) to its wholly owned subsidiary, ScentAI Inc. (“ScentAI”), in exchange for 116,000,000 shares of common stock to be issued by ScentAI.”

Glucotrack, Inc. issued common warrants to purchase 2,067,182 shares of warrant to the Investor for aggregate gross proceeds from the Private Placement of approximately $4.0 million.

“and together with the Pre-Funded Warrant Shares, the “Warrant Shares”) of Common Stock. The Company received aggregate gross proceeds from the Private Placement of approximately $4.0 million, before deducting estimated placement agent commissions and expenses in connection with the Private Placement, which are payable by the Company. The Securities Purchase Agreement”

Glucotrack, Inc. issued 1,033,591 pre-funded warrants of warrant to the Investor for $3.87 per Pre-Funded Warrant less the exercise price per Pre-Funded Warrant of $0.001 per share.

“Closing, the Company issued 1,033,591 pre-funded warrants (the “Pre-Funded Warrants”) to purchase 1,033,591 shares (the “Pre-Funded Warrant Shares”) of common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $3.87 per Pre-Funded Warrant less the exercise price per Pre-Funded Warrant of $0.001 per share, and (ii) common warrants to”

Profound Medical Corp. issued 921,428 shares of common stock to certain Canadian investors for $7.00 per share.

“On December 30, 2025, Profound Medical Corp. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with certain Canadian investors (the “Investors”) providing for the private placement of an aggregate of 921,428 shares of the Company’s common shares (the “Shares”), at a per share purchase price of $7.00 (the “Offering”) for aggregate gross proceeds of $6.45 million.”

Stardust Power Inc. issued approximately 419,162 shares of warrant to Lind Global Asset Management XIII LLC.

“Under the SPA, upon closing (which occurred on December 23, 2025) , the Company received gross proceeds of approximately $4.0 million in exchange for issuance to Lind of a Senior Secured Convertible Promissory Note in the amount of $4.8 million (the “Note”) and a Common Stock Purchase Warrant (the “Warrant”), for the purchase of approximately 419,162 shares (the “Warrant Shares”).”

Stardust Power Inc. issued convertible note to Lind Global Asset Management XIII LLC for gross proceeds of approximately $4.0 million.

“Under the SPA, upon closing (which occurred on December 23, 2025) , the Company received gross proceeds of approximately $4.0 million in exchange for issuance to Lind of a Senior Secured Convertible Promissory Note in the amount of $4.8 million (the “Note”) and a Common Stock Purchase Warrant (the “Warrant”), for the purchase of approximately 419,162 shares (the “Warrant Shares”).”

Nuvve Holding Corp. issued Warrants to purchase an aggregate of 2,534,856 shares of Common Stock of warrant to purchasers identified in Securities Purchase Agreement for aggregate purchase price of $5,400,000.

“On December 30, 2025, the Company closed the Private Placement (the “Closing”). At the Closing, the Company issued an aggregate of 6,000 shares of Series A Preferred Stock and Warrants to purchase an aggregate of 2,534,856 shares of Common Stock, for an aggregate purchase price of $5,400,000, representing a 10% original issue discount or $900 purchase price per share of each Series A Preferred Stock and accompanying Warrant.”

Nuvve Holding Corp. issued 6,000 shares of Series A Preferred Stock of preferred stock to purchasers identified in Securities Purchase Agreement for aggregate purchase price of $5,400,000.

“On December 30, 2025, the Company closed the Private Placement (the “Closing”). At the Closing, the Company issued an aggregate of 6,000 shares of Series A Preferred Stock and Warrants to purchase an aggregate of 2,534,856 shares of Common Stock, for an aggregate purchase price of $5,400,000, representing a 10% original issue discount or $900 purchase price per share of each Series A Preferred Stock and accompanying Warrant.”

Eagle Point Trinity Senior Secured Lending Co issued 2,319.8364 of its common shares of common stock to investing shareholder(s) for aggregate proceeds to the Fund of $23,312.50.

“On December 1, 2025, Eagle Point Trinity Senior Secured Lending Company (the “Fund”) issued and sold 2,319.8364 of its common shares of beneficial interest (the “Shares”), for aggregate proceeds to the Fund of $23,312.50.”

Silicon Valley Acquisition Corp. issued 425,000 units to the Sponsor and an aggregate of 200,000 units to the Representative of unit to the Sponsor and ... the Representative for $10.00 per Private Placement Unit.

“On December 24, 2025, simultaneously with the consummation of the Offering, the Company consummated the private placement of 425,000 units to the Sponsor and an aggregate of 200,000 units to the Representative (collectively, the “Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating gross proceeds of $6,250,000”

Clean Energy Technologies, Inc. issued 656,158 shares of common stock to two other investors for $283,855.

“Effective December 29, 2025, the Company entered into two additional subscription agreements (together with the Subscription Agreement the “ Subscription Agreements ”) with two other investors pursuant to which the Company sold the two other investors an aggregate of 656,158 shares of Company common stock (together with the Initial Shares the “ Shares ”) for $283,855.”

Clean Energy Technologies, Inc. issued 913,842 shares of common stock to an investor for $395,328.

“Effective December 24, 2025, Clean Energy Technologies, Inc. (the “ Company ”), entered into a subscription agreement (the “ Subscription Agreement ”) with an investor pursuant to which the Company sold the investor 913,842 shares of Company common stock (the “ Initial Shares ”) for $395,328.”

RYVYL Inc. issued common stock.

“RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”) today announced that its board of directors has approved a 1-for-35 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock”

SOBR Safe, Inc. issued warrants to purchase up to 96,774 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC for exercise price of $1.9375.

“HCW received warrants to purchase up to 96,774 shares of Common Stock at an exercise price of $1.9375”

SOBR Safe, Inc. issued Pre-Funded Warrants to purchase up to 920,324 shares of Common Stock of warrant to certain institutional investors for $1.5499 per Pre-Funded Warrant.

“to purchase up to 1,290,324 shares of Common Stock (each a “Series D Warrant” and with the Pre-Funded Warrants and Series C Warrants, the “Warrants”)) at a purchase price of $1.55 per share and accompanying Series C Warrant and Series D Warrant and $1.5499 per Pre-Funded Warrant and accompanying Series C Warrant and Series D Warrant. The Warrants are”

SOBR Safe, Inc. issued 370,000 shares of common stock of common stock to certain institutional investors for purchase price of $1.55 per share.

“to purchase up to 1,290,324 shares of Common Stock (each a “Series D Warrant” and with the Pre-Funded Warrants and Series C Warrants, the “Warrants”)) at a purchase price of $1.55 per share and accompanying Series C Warrant and Series D Warrant and $1.5499 per Pre-Funded Warrant and accompanying Series C Warrant and Series D Warrant. The Warrants are”

Presurance Holdings, Inc. issued one thousand six hundred (1,600) shares of preferred stock to Clarkston Companies, Inc. for $8,000,000 aggregate purchase price.

“On December 23, 2025 (the “Initial Issue Date”), Presurance Holdings, Inc. (the “Company”) sold one thousand six hundred (1,600) shares of its newly designated Series C Preferred Stock, no par value (the “Series C Preferred Stock” or the “Securities”), to Clarkston Companies, Inc. (the “Purchaser”), an entity affiliated with Jeffrey Hakala, a member of the Board of Directors of the Company, for an aggregate purchase price of eight million dollars ($8,000,000).”

PAVmed Inc. issued common stock.

“it will conduct a 1-for-30 reverse stock split of its common stock (the “Common Stock”). The reverse stock split will become effective on January 2, 2026, at 12:01 a.m. Eastern Time.”

TerrAscend Corp. issued convertible note to various sellers of Union Chill for aggregate principal amount of $9,000,000.

“On December 26, 2025, in connection with the closing of the Union Chill Transaction, the Company issued convertible promissory notes (the “Notes”) to the various sellers of Union Chill in the aggregate principal amount of $9,000,000 (the “Principal Amount”)”

T3 Defense Inc. issued 2,000,000 shares of common stock to escrow agent.

“The Company issued 2,000,000 shares of Common Stock to the escrow agent (the “Escrowed Shares”).”

PGIM Private Credit Fund issued 220 unregistered Class S and Class D common shares of unit to 110 separate accredited investors for $25,571 aggregate offering price; $25.35 per Class S and $25.29 per Class D common share; $1,000 per Note.

“As of December 1, 2025, PGIM Private Credit Fund (the “ Fund ”) issued and sold 220 of its unregistered Class S and Class D common shares of beneficial interest, $0.001 par value per share, for an aggregate offering price of approximately $25,571, reflecting a purchase price of $25.35 per Class S common share and $25.29 per Class D common share (with the final number of Class S and Class D common shares being determined on December 23, 2025).”

INSPIRE VETERINARY PARTNERS, INC. issued 3,000,000 shares of the Company's Class A common stock of common stock to Target Capital 1 LLC for cancellation of $150,000 of outstanding principal.

“On December 18, 2025, Inspire Veterinary Partners, Inc. (the “Company”), entered into a Cancellation and Exchange Agreement, (the “Agreement”) between the Company and Target Capital 1 LLC ( “Target”). Pursuant to the Agreement, the Company and Target agreed to cancel $150,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the “June Note”), in exchange for 3,000,000 shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”).”

Willow Tree Capital Corp issued approximately 3,101,737 common shares of common stock for $50.0 million aggregate offering price.

“On December 29, 2025, Willow Tree Capital Corporation (the “Company”) issued and sold approximately 3,101,737 common shares of beneficial interest (the “Shares”) of the Company for an aggregate offering price of $50.0 million.”